---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-054279"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:36:45.009524+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Unicycive stockholders approve Nasdaq 20% issuance and share increase at annual meeting

## Summary
- All four director nominees elected: Dr. Shalabh Gupta, Dr. Sandeep Laumas, Dr. Gaurav Aggarwal, Dr. Saraswati Kenkare-Mitra.
- Appointment of Grassi & Co. CPAs as independent auditor for FY2024 ratified with 35,666,926 votes for.
- Nasdaq 20% Issuance Proposal approved with 26,794,427 votes for, 262,272 against.
- Authorized Share Increase Proposal approved with 34,150,333 votes for, 1,735,688 against.
- Second amendment and restatement of 2021 Omnibus Equity Incentive Plan approved with 26,540,959 votes for.

## SEC filing metadata
- accession: 0001213900-24-054279
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024054279/0001213900-24-054279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024054279/ea0208180-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-054279
- JSON: https://secwatch.observer/filing/0001213900-24-054279.json
- Plain text: https://secwatch.observer/filing/0001213900-24-054279.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.